SCHEMBL19853807

SCHEMBL19853807

C=CC(=O)NCCOc1ccc(C2CCC(CCC3CCC(CCCCC)CC3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ZDHHC20 Q5W0Z9 1/20 0.40
▸ ZDHHC2 Q9UIJ5 1/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.40
▸ ITK Q08881 1/20 0.40
▸ ITGB3 P05106 3/20 0.39
▸ ITGA2B P08514 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ S1PR3 Q99500 1/20 0.39
▸ ITGAV P06756 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19856020 0.99 RAB9A (0.48) RAB9AALDH1A1LMNAMAPTZDHHC20
SCHEMBL20370456 0.96 RAB9A (0.46) RAB9AALDH1A1LMNAMAPTZDHHC20
SCHEMBL20370465 0.96 RAB9A (0.46) RAB9AALDH1A1LMNAMAPTZDHHC20
SCHEMBL19854562 0.94 RAB9A (0.47) RAB9AALDH1A1LMNAMAPTZDHHC20
SCHEMBL20370561 0.93 RAB9A (0.44) RAB9AALDH1A1LMNAMAPTZDHHC20
SCHEMBL20370575 0.88 RAB9A (0.39) RAB9AALDH1A1LMNAMAPTCYP2C9
SCHEMBL20370586 0.88 RAB9A (0.39) RAB9AALDH1A1LMNAMAPTCYP2C9
SCHEMBL23635458 0.88 RAB9A (0.47) RAB9AALDH1A1LMNAMAPTCYP2C9
SCHEMBL19855140 0.87 RAB9A (0.39) RAB9AALDH1A1LMNAMAPTITK
SCHEMBL19854954 0.87 RAB9A (0.39) RAB9AALDH1A1LMNAMAPTZDHHC20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 RAB9A 4014/4885ALDH1A1 3826/4885LMNA 1840/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 RAB9A 4014/4885ALDH1A1 3826/4885LMNA 1840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback